A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

NCT04404660 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: AUTO1

Sponsor

Autolus Limited